Menu
GWAS Study

European-based polygenic risk score and genome-wide association study of B-cell non-Hodgkin lymphoma subtypes in Israeli Jews and Palestinian Arabs.

Kleinstern G, Robinson DP, Abu Seir R et al.

40887045 PubMed ID
GWAS Study Type
1120 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

KG
Kleinstern G
RD
Robinson DP
AS
Abu Seir R
PR
Perlman R
LJ
Liu J
JN
Jebrini N
EH
Elyan H
BY
Ben Yehuda D
SS
Slager SL
PO
Paltiel O
Chapter II

Abstract

Summary of the research findings

Among individuals of European Ancestry (EA), genome-wide association studies (GWAS) have identified single nucleotide polymorphisms (SNPs) and polygenic risk scores (PRSs) associated with non-Hodgkin lymphoma (NHL) risk. We evaluated subtype-specific PRSs, based on established EA-SNPs, in Israeli Jews (IJ) and Palestinian Arabs (PA) and performed a GWAS in the combined ethnic groups to identify new loci. We included three common pathologically confirmed subtypes: diffuse large B-cell (DLBCL), follicular (FL) and marginal zone (MZL) lymphomas. Controls were frequency matched to cases by age and sex. Among 752 IJ (201-DLBCL; 130-FL; 54-MZL/367-controls) and 593 PA (203-DLBCL; 41-FL/349-controls), we computed PRSs weighted by EA-derived effect estimates and used logistic regression models adjusted for confounders. In the combined ethnic groups of IJ and PA, subtype-specific PRSs were significantly associated with the corresponding subtype, with a 1.69-fold, 2.21-fold and 2.26-fold risk for DLBCL, FL and MZL, respectively; however, these effect sizes were attenuated compared to those reported in EA and varied by ethnicity. In the GWAS of the combined ethnic groups, two novel SNPs in the 6p21.32 locus were associated with DLBCL risk. Additional GWAS studies are needed among Jewish and Arab populations to improve genetic risk prediction for NHL in these ethnic groups.

175 Israeli Jewish cases, 324 Israeli Jewish controls, 229 Palestinian Arab or North African Israeli Jewish cases, 392 Palestinian Arab or North African Israeli Jewish controls

Chapter III

Study Statistics

Key metrics and study information

1120
Total Participants
GWAS
Study Type
No
Replicated
Other, Greater Middle Eastern (Middle Eastern, North African or Persian)
Ancestry
Israel, Occupied Palestinian Territory
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.